Abstract
The emergence and outgrowth of a population of tumour cells resistant to multiple drugs is a major problem in the chemotherapeutic treatment of cancer. We have used highly drug-resistant cell lines developed in vitro to study the molecular basis of multidrug resistance. In these cell lines high levels of resistance are frequently associated with amplification and overexpression of a small group of genes termed mdr (refs 1–3) or gp170 (ref. 4). Direct evaluation of the role of these genes in multidrug resistance has awaited the isolation of a member of this gene family in a biologically active form. Here we report the isolation of DNA clones complementary to the cellular messenger RNA transcripts of mdr genes and show that high-level expression of a full-length complementary DNA clone in an otherwise drug-sensitive cell confers a complete multidrug-resistant phenotype. Our results demonstrate that overexpression of a single member of the mdr group is sufficient to confer drug resistance. Furthermore, because the cDNA was isolated from a drug-sensitive cell, mutations in the primary sequence of mdr are not required to produce a multi-drug-resistance phenotype.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gros, P., Croop, J., Roninson, I. B., Varshavsky, A. & Housman, D. E. Proc. natn. Acad. Sci. U.S.A. 83, 337–341 (1986).
Gros, P., Croop, J., Mukayama, T., Fallows, D. A. & Housman, D. E. J. cell. Biochem. Abstr. 10A, 51 (1986).
Roninson, I. B. et al. Proc. natn. Acad. Sci. U.S.A. 83, 4538 (1986).
Riordan, J. R. et al. Nature 316, 817–819 (1985).
Roninson, I. B. Nucleic Acids Res. 11, 5413–5431 (1983).
Roninson, I. B., Abelson, H. T., Housman, D. E., Howell, N. & Varshavsky, A. Nature 309, 626–628 (1984).
Ling, V. & Thompson, L. H. J. cell. Physiol. 83, 103–111 (1974).
Howell, N., Belli, T. A., Zaczkiewics, L. T. & Belli, J. A. Cancer Res. 44, 4023–4030 (1984).
Fojo, A. T., Whang-Peng, J., Gottesman, M. M. & Pastan, I. Proc. natn. Acad. Sci. U.S.A. 82, 7661–7664 (1985).
Kaufman, R. J. & Sharp, P. A. Molec. cell. Biol. 2, 1304–1319 (1982).
Wong, G. G. et al. Science 228, 810–814 (1985).
Pollard, J. W. & Stanners, C. P. J. cell. Physiol. 98, 571–586 (1979).
Shen, D. W. et al. Science 232, 643 (1986).
Kartner, N., Riordan, J. R. & Ling, V. Science 221, 1285–1289 (1983).
Gerlach, J., Kartner, N., Bell, D. R. & Ling, V. Cancer Surv. (in the press).
Ling, V. et al. Cancer Treat. Rep. 67, 869–874 (1983).
Inaba, M. et al. Cancer Res. 39, 2200–2203 (1979).
Norrander, J., Kempe, T. & Messing, J. Gene 26, 101–106 (1983).
Feinberg, A. P. & Vogelstein, B. Analyt. Biochem. 132, 61–13 (1983).
Grosveld, F. G. et al. Nucleic Acids Res. 10, 6715–6731 (1982).
Paige, C. J., Kincade, P. N. & Ralph, P. J. Immun. 121, 641–648 (1978).
Gubler, V. & Hoffman, B. J. Gene 25, 263–269 (1983).
Benton, W. D. & Davis, R. W. Science 196, 180–182 (1977).
Wigler, M. et al. Proc. natn. Acad. Sci. U.S.A. 76, 1373–1377 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gros, P., Neriah, Y., Croop, J. et al. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323, 728–731 (1986). https://doi.org/10.1038/323728a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/323728a0
This article is cited by
-
Revisiting the role of ABC transporters in multidrug-resistant cancer
Nature Reviews Cancer (2018)
-
Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention
Cardiovascular Toxicology (2018)
-
Profiling gene mutations, translocations, and multidrug resistance in pediatric acute lymphoblastic leukemia: a step forward to personalizing medicine
Medical Oncology (2016)
-
EAPP: Gatekeeper at the crossroad of apoptosis and p21-mediated cell-cycle arrest
Oncogene (2011)
-
Methylation of WTH3, a possible drug resistant gene, inhibits p53 regulated expression
BMC Cancer (2008)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.